Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Fish Biol ; 92(1): 165-176, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29178292

RESUMO

To analyse the survival, pathway and time of embryo development in the annual fish Austrolebias nigrofasciatus eggs were monitored in four liquid media and two damp media under experimental conditions for 130 days until their development was complete. Eggs kept in the same breeding water from oviposition remained in diapause I (DI) during all experiments. In constrast, up to the stage prior to entering diapause II (DII), the other media had no influence on development. Embryos at this stage (DII), however, show longer development time when treated in medium with water and powdered coconut shell so that about 80% of embryos remained in DII at 100 days. In contrast, all other treatments had a significantly lower proportion of embryos remaining in DII. When treated with Yamamoto's solution in humid media, embryos showed the fastest development. The first fully developed embryos (DIII) were seen at 27 days after oviposition. It took an average of 46-58 days for 50% of eggs in each treatment to reach DIII. Compared with other studies, survival in all incubation media was high at between 70 and 98%. Taken together, it can be concluded that all incubation media were found to be viable for maintaining embryos. Altering developmental trajectories through the manipulation of diapauses in different media makes this species a potential model organism for laboratory studies.


Assuntos
Ciprinodontiformes/embriologia , Embrião não Mamífero/efeitos dos fármacos , Desenvolvimento Embrionário , Animais , Cruzamento , Meios de Cultura/química , Feminino , Estágios do Ciclo de Vida , Oviposição , Fatores de Tempo
2.
Climacteric ; 19(3): 299-302, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27031181

RESUMO

Objective To evaluate the effect of short-term hormone replacement therapy with tibolone 2.5 mg daily on endothelial function of healthy postmenopausal women, using flow-mediated dilation (FMD) of the brachial artery. Methods We performed a randomized, double-blinded, placebo-controlled study. A total of 100 healthy postmenopausal women were randomly allocated to receive tibolone (n = 50) or placebo (n = 50) for 28 days. Measurement of the FMD of the brachial artery was performed before and after the use of tibolone and placebo. Results A total of 31 women completed the study in the tibolone group, and 32 women completed the study in the control group. The results of the FMD measurements obtained from the women in the two groups before treatment were similar (0.018 and 0.091, for tibolone and placebo, p = 0.57). The values of the FMD in women who used tibolone and placebo, before and after the treatment, were similar in both groups. The numbers of women who presented an increase in the values of the FMD in both groups were also similar. Conclusion Our results demonstrate that the administration of 2.5 mg tibolone to healthy postmenopausal women for 28 days does not promote endothelial-dependent vasodilation, measured by FMD of the brachial artery.


Assuntos
Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/fisiologia , Moduladores de Receptor Estrogênico , Norpregnenos/administração & dosagem , Artéria Braquial/fisiologia , Método Duplo-Cego , Feminino , Terapia de Reposição Hormonal , Humanos , Pessoa de Meia-Idade , Norpregnenos/efeitos adversos , Placebos , Pós-Menopausa , Estudos Prospectivos , Vasodilatação/efeitos dos fármacos
3.
Oncogenesis ; 3: e123, 2014 Oct 20.
Artigo em Inglês | MEDLINE | ID: mdl-25329722

RESUMO

The tumor microenvironment has a dynamic and usually cancer-promoting function during all tumorigenic steps. Glioblastoma (GBM) is a fatal tumor of the central nervous system, in which a substantial number of non-tumoral infiltrated cells can be found. Astrocytes neighboring these tumor cells have a particular reactive phenotype and can enhance GBM malignancy by inducing aberrant cell proliferation and invasion. The tumor suppressor p53 has a potential non-cell autonomous function by modulating the expression of secreted proteins that influence neighbor cells. In this work, we investigated the role of p53 on the crosstalk between GBM cells and astrocytes. We show that extracellular matrix (ECM) from p53(+/-) astrocytes is richer in laminin and fibronectin, compared with ECM from p53(+/+) astrocytes. In addition, ECM from p53(+/-) astrocytes increases the survival and the expression of mesenchymal markers in GBM cells, which suggests haploinsufficient phenotype of the p53(+/-) microenvironment. Importantly, conditioned medium from GBM cells blocks the expression of p53 in p53(+/+) astrocytes, even when DNA was damaged. These results suggest that GBM cells create a dysfunctional microenvironment based on the impairment of p53 expression that in turns exacerbates tumor endurance.

4.
Clin Exp Obstet Gynecol ; 38(3): 232-5, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21995153

RESUMO

OBJECTIVE: To evaluate thromboelastographic parameters and fibrinogen levels in women treated with transdermal 17beta estradiol. METHODS: 29 menopausal women with a history of venous thromboembolic disease were included. Nine patients composed the treatment (HT) group and 20 the control group. Coagulation was assessed by thromboelastography in samples of whole blood and platelet-poor plasma (PPP). The following thromboelastographic variables were measured: time for initial coagulation (R), blood clotting speed (K and the alpha angle), clot tensile strength (MA and G), global index of coagulation (CI) and fibrinolysis (LY30) and fibrinogen levels. RESULTS: There were no differences in the other parameters comparing both groups. Fibrinogen levels showed a 13.77 +/- 19.94% reduction in the HT group and a 5.51 +/- 8.09% increase in the control group after 6 months. CONCLUSIONS: Our data suggested that transdermal estrogen may not increase blood coagulability, but that it reduces fibrinogen levels in HT women.


Assuntos
Estradiol/administração & dosagem , Terapia de Reposição de Estrogênios , Estrogênios/administração & dosagem , Fibrinogênio/análise , Tromboembolia Venosa/sangue , Administração Cutânea , Adulto , Análise de Variância , Feminino , Humanos , Pessoa de Meia-Idade , Projetos Piloto , Tromboelastografia
5.
Climacteric ; 14(1): 140-5, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20497031

RESUMO

OBJECTIVES: To evaluate the effects of acupuncture and sham-acupuncture on women with menopausal symptoms as reflected in the intensity of their hot flushes and the Kupperman Menopausal Index (KMI). METHOD: This was a randomized, single-blind, placebo-controlled, cross-over trial with 81 patients assigned to two groups: Group 1 received 12 months of acupuncture, then 6 months of sham-acupuncture treatment (n = 56) and Group 2 received 6 months of sham-acupuncture, then 12 months of acupuncture treatment (n = 25). The needles were inserted in a harmonic craniocaudal manner at a depth of about 2 cm, and each session lasted approximately 40 min. The efficacy of acupuncture in ameliorating the climacteric symptoms of patients in postmenopause was determined through the KMI and the intensity of hot flushes. The analysis of variance method for two factors and repeated measures was applied. RESULTS: The baseline values of the women in both groups were similar for the KMI score and number of hot flushes. At the end of 6 months, the values for the KMI and hot flushes for the women in Group 1 were lower than those of the women in Group 2 (p < 0.05). After 12 months, the KMI and hot flush data were similar in both groups. After 18 months, the values of the KMI and hot flushes for the women in Group 2 for were lower than those of the women in Group 1 (p < 0.05). CONCLUSION: Acupuncture treatment for relieving menopausal symptoms may be effective for decreasing hot flushes and the KMI score in postmenopausal women.


Assuntos
Terapia por Acupuntura , Fogachos/terapia , Climatério , Estudos Cross-Over , Feminino , Humanos , Pessoa de Meia-Idade , Estudos Prospectivos , Método Simples-Cego
6.
Curr Med Res Opin ; 25(11): 2589-99, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19731994

RESUMO

OBJECTIVES: To assess the influence of vitamins B1, B6 and B12 on the analgesia success achieved by diclofenac in subjects with acute lumbago. RESEARCH DESIGN AND METHODS: A randomised, double blind controlled clinical study in parallel groups, in which subjects received twice-daily oral administration of either the combination therapy, Group DB (50 mg diclofenac plus 50 mg thiamine, 50 mg pyridoxine and 1 mg cyanocobalamin) or diclofenac monotherapy, Group D (50mg diclofenac). The study period lasted a maximum of 7 days. If sufficient pain reduction was achieved (defined as Visual Analogue Scale <20 mm and patient's satisfaction), subjects could withdraw from the treatment after 3 or 5 days. All subjects gave written informed consent to participate in the study. MAIN OUTCOME MEASURES: The primary confirmatory study objective was to determine the number of patients with sufficient pain reduction after 3 days of treatment. RESULTS: Three hundred and seventy-two subjects were allocated at random to either treatment group: Group DB - 187 subjects and Group D - 185 subjects. After 3 days of treatment, a statistically significant higher proportion of subjects in Group DB (n = 87; 46.5%) than in Group D (n = 55; 29%) terminated the study due to treatment success (chi(2): 12.06; p = 0.0005). Furthermore, the combination therapy yielded superior results in pain reduction, improvement of mobility and functionality. Drug safety monitoring profile throughout the trial was within the expected safety profile of diclofenac. CONCLUSIONS: The combination of diclofenac with B vitamins was superior to diclofenac monotherapy in lumbago relief after 3 days of treatment. As a study drawback, daily VAS measurements were only recorded until subject withdrawal from treatment, whether after 3, 5, or 7 days. There were no differences in safety profile between the two study groups.


Assuntos
Diclofenaco/administração & dosagem , Dor Lombar/tratamento farmacológico , Complexo Vitamínico B/administração & dosagem , Adolescente , Adulto , Idoso , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/efeitos adversos , Diclofenaco/efeitos adversos , Relação Dose-Resposta a Droga , Método Duplo-Cego , Esquema de Medicação , Quimioterapia Combinada/efeitos adversos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Complexo Vitamínico B/efeitos adversos , Adulto Jovem
12.
Fertil Steril ; 75(2): 282-7, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11172828

RESUMO

OBJECTIVE: To determine the effects of hormone replacement therapy on plasma concentrations of free and total insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3. DESIGN: Clinical study. SETTING: Gynecologic clinic at a university hospital. PATIENT(S): Seventy-one postmenopausal women. INTERVENTION(S): Six cycles of four different hormonal replacement therapy regimens: oral conjugated estrogens, transdermal estradiol, oral conjugated estrogens and norethisterone, and transdermal estradiol and norethisterone acetate. MAIN OUTCOME MEASURE(S): Blood samples were collected before and after treatment for measurement of free and total IGF-I, IGFBP-1, and IGFBP-3. RESULT(S): Conjugated estrogen replacement therapy is associated with a decrease in plasma concentration of total IGF-I and increase in concentrations of free IGF-I and IGFBP-1. Transdermal estrogens have no effect on total and free IGF-I and IGFBP-1 concentrations. Oral norethisterone plus conjugated estrogens increased free IGF-I and IGFBP-1 concentrations but did not change IGF-I concentrations. Transdermal conjugated estrogens plus norethisterone acetate increased free IGF-I concentrations but not total IGF-I or IGFBP-1 concentrations. The plasma concentration of IGFBP-3 did not change in any group. CONCLUSION(S): Alterations in total IGF-I concentration can occur depending on the route of hormone replacement therapy administration. Free IGF-I concentrations were elevated in all study groups except that treated with transdermal estrogens.


Assuntos
Terapia de Reposição de Estrogênios/efeitos adversos , Proteína 1 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Fator de Crescimento Insulin-Like I/análise , Pós-Menopausa , Administração Cutânea , Administração Oral , Glicemia/análise , Estrogênios/administração & dosagem , Estrogênios Conjugados (USP)/administração & dosagem , Feminino , Humanos , Insulina/sangue , Noretindrona/administração & dosagem
13.
J Pharmacol Toxicol Methods ; 46(3): 137-43, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-12183189

RESUMO

INTRODUCTION: Certain drugs can induce tremor in small animals and can be used as Parkinson's disease or essential experimental tremor models. However, the use of arbitrary scales for evaluating tremor in experimental models is limited by observer subjectivity. Progress in electronics and computer science has allowed a more precise quantification of tremor. The objective of the present study was to validate a newly developed low-cost method of spectral registration and analysis of tremor in free-moving rats. METHODS: Male Wistar rats, 3-4 months of age, previously placed for 5 min inside a sensor cage, were administered with different doses of eserine (0.25-1.5 mg/kg), oxotremorine (0.25-1.5 mg/kg) or harmaline (7.5-60 mg/kg). Drug-induced tremor was recorded during 10 min using a computerized system composed of force transducers, a signal conditioning circuit, a digitizing interface and a microcomputer. The signal transmitted to the computer was quantified, stored and analyzed for its amplitude and frequency by means of specific programs. RESULTS: Tremor was induced with an amplitude that was dose-dependent for all drugs used. Tremor frequency was dose-dependent for oxotremorine and eserine, but not for harmaline. The performance of the system was compared with that of other systems described in behavioral instrumentation literature. DISCUSSION: The present data indicate that the new system is capable of detecting the tremor induced by drugs, and that the programs used for spectral analysis allow the quantification of the amplitude and the frequency of the tremor in free-moving rats.


Assuntos
Processamento de Sinais Assistido por Computador , Tremor/induzido quimicamente , Animais , Relação Dose-Resposta a Droga , Harmalina/farmacologia , Masculino , Oxotremorina/farmacologia , Ratos , Ratos Wistar
14.
Int J Gynaecol Obstet ; 62(1): 63-7, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9722128

RESUMO

OBJECTIVE: To determine the efficacy of fluoxetine (10 mg), alprazolam, propanolol and pyridoxine in the treatment of severe premenstrual syndrome (PMS). METHOD: One-hundred and twenty women were divided into four groups of 30 patients. Patients were submitted to a randomized, double-blind, placebo-controlled treatment and were given 3 months of placebo and 3 months of active drug. The active drug was pyridoxine (300 mg/day) in group 1; alprazolam (0.75 mg/day) in group 2; fluoxetine (10 mg/day) in group 3; and propanolol (20 mg/day and 40 mg during the menstrual period) in group 4. RESULTS: Fluoxetine in 10-mg doses obtained a mean reduction of 65.4% in symptoms, followed by propanolol (58.7%), alprazolam (55.6%), pyridoxine (45.3%) and placebo (39.4-46.1%). CONCLUSION: Fluoxetine in 10-mg doses presented the best results for treating premenstrual syndrome.


Assuntos
Alprazolam/uso terapêutico , Ansiolíticos/uso terapêutico , Fluoxetina/uso terapêutico , Síndrome Pré-Menstrual/tratamento farmacológico , Piridoxina/uso terapêutico , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Método Duplo-Cego , Feminino , Humanos , Resultado do Tratamento
15.
Mem Inst Oswaldo Cruz ; 92(4): 545-8, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9361751

RESUMO

An artificial feeding system was used where citrated bovine blood was offered to male and female Amblyomma cajennense. Vestiges of blood, sweat, hair and exfoliated skin were used as phago-stimulants placed on the surface of the silicone membrane. The ticks were collected, as engorged nymphs, from naturally infested equines, with the ecdysis occurring in the laboratory. Four hundred ticks were used, 50% being female, at three to four weeks post-ecdysis. Vestiges of blood on the silicone membrane were the most efficient phago-stimulant and the association of vestiges of blood and sweat residue smears yielded better results compared to the other phago-stimulants used.


Assuntos
Entomologia/métodos , Carrapatos/fisiologia , Animais , Feminino , Masculino , Silicones
16.
Mem Inst Oswaldo Cruz ; 92(4): 553-8, 1997.
Artigo em Português | MEDLINE | ID: mdl-9361752

RESUMO

Rhodnius pictipes (Hemiptera, Reduviidae) from Serra Norte, State of Pará, Brazil, acclimatized in an insectary at the Laboratório Nacional e Internacional de Referência em Taxonomia de Triatomíneos, Departamento de Entomologia, Instituto Oswaldo Cruz, were fed through a silicone membrane. In order to know the viability and the efficiency of this membrane compared with insects fed on mice, the number of bloodmeals taken, period of development of the five nymphal instars, longevity of adults, average amount of blood intake in each meal and percent of mortality were observed. A total of 310 insects, were used, comprising 50 nymphs of each instar, as well as 30 male and 30 female adults. Insects fed artificially had reduced minimal and maximal periods of development than the group fed on mice. The largest relative increase of body weight was observed in the 2nd instar followed by the 1st, and the amount of blood ingested increased during the development, to the 5th instar for both groups. There were no significant differences between the groups fed artificially and in vivo according to Tukey's test for p > 0.05. The percent of mortality in the 1st instar was 18% for artificially fed and 16% for the group fed on mice; these percentages decreased as insects developed until the 4th instar, without mortality, returning to increase in the 5th instar. R. pictipes was shown to be easily adaptable to artificial feeding, and could be considered as an important and viable experimental model.


Assuntos
Entomologia/métodos , Rhodnius/crescimento & desenvolvimento , Animais , Doença de Chagas/transmissão , Feminino , Masculino , Camundongos , Silicones
17.
Rev Hosp Clin Fac Med Sao Paulo ; 52(2): 111-7, 1997.
Artigo em Português | MEDLINE | ID: mdl-9435406

RESUMO

Since 1989, we have identified 25 patients with Lyme disease, 15 in early and 10 in latent stage, supporting its existence in Brazil, according to following reasons: 1) presence of clinical manifestations compatible with Lyme disease, with cutaneous, articular, nervous system and rarely cardiac envolvement; 2) presence of antibodies against Borrelia burgdorferi; 3) follow up of acute cases show sorologycal changes; 4) good antibiotic response at early stage of disease and only satisfactory in latent form; 5) mapping of risk areas, according to geographycal distribution of patients; 6) presence and identification of Ixodid ticks; 7) identification of micro-organism like borrelias in human, wild animals and ticks cultures, seen by dark field microscope; 8) sorology done in dogs and oxes, confirm existence of risk areas for Lyme disease.


Assuntos
Insetos Vetores , Doença de Lyme/epidemiologia , Carrapatos/microbiologia , Adulto , Animais , Grupo Borrelia Burgdorferi/isolamento & purificação , Brasil/epidemiologia , Criança , Pré-Escolar , Feminino , Humanos , Doença de Lyme/complicações , Doença de Lyme/diagnóstico , Doença de Lyme/tratamento farmacológico , Masculino , Pessoa de Meia-Idade
18.
Parasitol Res ; 83(7): 690-7, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9272560

RESUMO

The induction of protective immunity to Leishmania amazonensis was investigated by injection of parasite clones of low and medium virulence into susceptible mice. To this end, L. amazonensis were cloned by limiting dilution and the clones' virulence was evaluated by the course of infection in susceptible mice. Clones originally derived from the spleen showed virulence variations in comparison with that of the parental population (PP) of parasites. Two low-virulence clones (SP 5 and SP 20) and one medium-virulence clone (SP 11), representative of the spectrum of derived clones, were compared with virulent parasites and with an avirulent strain (Josefa) as to their ability to induce T-cell immune responses and to protect BALB/c mice from infection with the virulent L. amazonensis PP. Clone SP 20 and clone SP 11 induced partial protection when injected by the intravenous and intradermal route, respectively. The avirulent Josefa strain induced neither T-cell responses nor protection. Low-virulence L. amazonensis clones can therefore be additional tools in vaccine investigation.


Assuntos
Leishmania mexicana/imunologia , Leishmaniose Cutânea/imunologia , Animais , Anticorpos Antiprotozoários/imunologia , Antígenos de Protozoários/imunologia , Hipersensibilidade Tardia/imunologia , Imunização , Leishmania mexicana/patogenicidade , Leishmaniose Cutânea/prevenção & controle , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL
19.
Vaccine ; 13(18): 1804-8, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8701597

RESUMO

Current methods for the control of the cattle tick Boophilus microplus infestations are not effective and the parasite remains a serious problem for the cattle industry in tropical and sub-tropical areas. Recent advances have introduced the possibility for the immunological control of the parasite through the use of recombinant vaccines. Recently, it was shown that the recombinant vaccine Gavac (Heber Biotec S.A.) is able to control B. microplus populations in artificially infected grazing dairy cattle in Cuba. To assay the effect of the vaccine on a different B. microplus strain and under different ecological conditions, we conducted a trial in Brazil on grazing dairy and beef pure and cross-bred cattle under natural infestation conditions. A farm in the northeast of the state of Sao Paulo was selected and two groups of animals per breed were included in the experiment and were maintained grazing on separate but similar pastures. For each breed, one group was vaccinated with the vaccine Gavac and the second group was not vaccinated and was employed as a control. In vaccinated cattle, during 36 weeks of experiment, the average infestation rate was maintained below 78 ticks per animal while average infestation peaks (mean +/- S.E.) of 144 +/- 44 ticks per animal (for dairy cross-bred cattle) and 195 +/- 42 ticks per animal (for beef cross-bred cattle) were recorded in the control groups. Tick infestation rates showed statistical significant differences (p = 0.04) between both experimental groups throughout the experiment. These results clearly showed, as in the Cuban study, that the vaccine controlled tick numbers in successive generations in the field.


Assuntos
Antígenos/imunologia , Doenças dos Bovinos/prevenção & controle , Doenças Transmitidas por Carrapatos/veterinária , Vacinação , Vacinas Sintéticas/imunologia , Análise de Variância , Animais , Brasil , Cruzamento , Bovinos , Cruzamentos Genéticos , Doenças Transmitidas por Carrapatos/prevenção & controle
20.
Food Chem Toxicol ; 32(5): 477-9, 1994 May.
Artigo em Inglês | MEDLINE | ID: mdl-8206446

RESUMO

Because of the importance of stannous chloride in various fields of human endeavour, the potential genotoxicity of this reducing agent was evaluated by measurement of either the inactivation or the induction of SOS responses in bacteria. Escherichia coli strains used in this work (wild type, uvrA, recA, lexA and uvrA recA) were treated with stannous chloride; the wild type was found to be the most resistant and the double mutant, the most sensitive strain. As these strains present mutations on specific genes for the repair of DNA, stannous chloride would appear to be capable of inducing and/or producing lesions in DNA and, thus, can be considered to be a potential genotoxic agent. This capability was confirmed by the lysogenic induction of E. coli K12 (lambda) (Inductest) and by microscopic observation of E. coli B filamentation.


Assuntos
Testes de Mutagenicidade/métodos , Mutagênicos/toxicidade , Compostos de Estanho/toxicidade , Reparo do DNA/genética , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Escherichia coli/crescimento & desenvolvimento , Lisogenia/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA